PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.56%
Revenue growth under 50% of MRVL's 12.58%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-0.22%
Negative gross profit growth while MRVL is at 58.09%. Joel Greenblatt would examine cost competitiveness or demand decline.
-0.70%
Negative EBIT growth while MRVL is at 87.50%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-1.65%
Negative operating income growth while MRVL is at 87.50%. Joel Greenblatt would press for urgent turnaround measures.
0.17%
Net income growth under 50% of MRVL's 77.38%. Michael Burry would suspect the firm is falling well behind a key competitor.
1.21%
EPS growth under 50% of MRVL's 77.79%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
0.82%
Diluted EPS growth under 50% of MRVL's 77.79%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.76%
Share reduction while MRVL is at 0.92%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.75%
Reduced diluted shares while MRVL is at 0.91%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-0.09%
Dividend reduction while MRVL stands at 1.29%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
56.45%
OCF growth above 1.5x MRVL's 19.16%. David Dodd would confirm a clear edge in underlying cash generation.
68.74%
Positive FCF growth while MRVL is negative. John Neff would see a strong competitive edge in net cash generation.
91.35%
Positive 10Y revenue/share CAGR while MRVL is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
37.79%
5Y revenue/share CAGR above 1.5x MRVL's 14.16%. David Dodd would look for consistent product or market expansions fueling outperformance.
42.33%
3Y revenue/share CAGR above 1.5x MRVL's 12.94%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
184.81%
Positive long-term OCF/share growth while MRVL is negative. John Neff would see a structural advantage in sustained cash generation.
73.82%
5Y OCF/share CAGR above 1.5x MRVL's 34.40%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
42.20%
Positive 3Y OCF/share CAGR while MRVL is negative. John Neff might see a big short-term edge in operational efficiency.
262.30%
Positive 10Y CAGR while MRVL is negative. John Neff might see a substantial advantage in bottom-line trajectory.
93.27%
Positive 5Y CAGR while MRVL is negative. John Neff might view this as a strong mid-term relative advantage.
64.93%
3Y net income/share CAGR above 1.5x MRVL's 7.71%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
57.46%
Below 50% of MRVL's 125.59%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
42.87%
Below 50% of MRVL's 131.44%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
65.35%
3Y equity/share CAGR similar to MRVL's 64.32%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
570.52%
Dividend/share CAGR of 570.52% while MRVL is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
129.76%
5Y dividend/share CAGR above 1.5x MRVL's 1.32%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
49.28%
3Y dividend/share CAGR above 1.5x MRVL's 1.54%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-6.85%
Firm’s AR is declining while MRVL shows 24.52%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
9.32%
Inventory shrinking or stable vs. MRVL's 36.79%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
5.40%
Similar asset growth to MRVL's 5.66%. Walter Schloss finds parallel expansions or investment rates.
3.73%
50-75% of MRVL's 5.44%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
9.57%
We have some new debt while MRVL reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
4.11%
R&D growth drastically higher vs. MRVL's 1.32%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
2.13%
We expand SG&A while MRVL cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.